---
layout: post
title: "Screening Framework Guidance for Providers and Users of Synthetic Oligonucleotides"
date: 2026-02-05 18:58:59 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-09210
original_published: 2022-04-29 00:00:00 +0000
significance: 8.00
---

# Screening Framework Guidance for Providers and Users of Synthetic Oligonucleotides

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** April 29, 2022 00:00 UTC
**Document Number:** 2022-09210

## Summary

The Assistant Secretary for Preparedness and Response is issuing this revised guidance on a screening framework guidance for providers and users of synthetic oligonucleotides. The Revised Guidance sets forth recommended baseline standards for the gene and genome synthesis industry, as well as best practices for Institutions, Principal Users, End Users, and Third-Party Vendors of oligonucleotides, regarding screening orders and maintaining records consistent with current U.S. regulations. In addition, this Revised Guidance seeks to encourage best practices to address biosecurity concerns associated with the potential misuse of synthetic oligonucleotides to bypass existing regulatory controls and commit unlawful acts.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/04/29/2022-09210/screening-framework-guidance-for-providers-and-users-of-synthetic-oligonucleotides)
- API: https://www.federalregister.gov/api/v1/documents/2022-09210

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
